Back

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021 (07:15 - 07:24)
Organised by:
Congress Presentation Part of: Biomarkers to improve prognostication in heart failure: what's new? Comorbidities ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Associate Professor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study
Doctor S. Kiddle (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy
Doctor R. Klingenberg (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure
Doctor G. Vergaro (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients
Doctor A. Reese-Petersen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers to improve prognostication in heart failure: what's new?

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 07:15 CET
You may be interested in
thumbnail
Congress Presentation
Spectrum of non-cardiac comorbidities
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Presentation
Clinical characteristics of newly diagnosed vs. chronic heart failure patients in Spain: SEC-Excelente registry results.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources